Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramChief Commercial OfficerCIK 0001827505
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Sweeny NicoleChief Commercial Officer |  KALVKalVista Pharmaceuticals, Inc.Disposition to issuer | D | — 40.0K sh | Jun 11, 2026 traded Jun 11, 2026 | |
Sweeny NicoleChief Commercial Officer |
| KALVKalVista Pharmaceuticals, Inc. Disposition to issuer |
| D |
| — 59.3K sh |
| Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 93.8K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 100.0K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 68.8K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 27 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $38K 1,862 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 9 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 9 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 11 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Grant or award | A | — 100.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 48 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Open-market sale | SELL | $51K 3,813 sh | Dec 4, 2025 traded Nov 24, 2025 |
| 23 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 5,000 sh | Dec 4, 2025 traded Nov 22, 2025 |
| 23 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Dec 4, 2025 traded Nov 21, 2025 |
| 23 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 6,250 sh | Dec 4, 2025 traded Nov 21, 2025 |
| 23 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Option exercise | M | — 5,000 sh | Dec 4, 2025 traded Nov 22, 2025 |